| Study to Determine the Effect of Ketoconazole on the Pharmacokinetics of GDC-0980 (NCT01473316) | Genentech, Inc. | 2011-11-01 |
| A Trial to Investigate the Pharmacokinetics (PK) of Single Doses of 200 µg, 400 µg and 2 x 400 µg of Intranasal Fentanyl Spray (INFS) in Healthy Subjects (NCT01497288) | Takeda | 2011-11-01 |
| Study to Evaluate Safety, Tolerability, PK and PD of ALXN1007 in Healthy Subjects (NCT01454986) | Alexion Pharmaceuticals, Inc. | 2011-11-01 |
| A Phase I-II Open Label Non-Randomized Study Using TL32711 for Patients With Acute Myelogenous Leukemia, Myelodysplastic Syndrome and Acute Lymphoblastic Leukemia (NCT01486784) | Abramson Cancer Center at Penn Medicine | 2011-11-01 |
| Safety Study of Anti-Programmed Death-Ligand 1 in Hematologic Malignancy (NCT01452334) | Bristol-Myers Squibb | 2011-11-01 |
| A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine. (NCT01464320) | Abbott | 2011-11-01 |
| Study to Evaluate the PK of BMS-927711 in Patient With Migraine During Acute Migraine and Non-migraine Condition (NCT01445067) | Pfizer | 2011-11-01 |
| Study to Assess the Effects of Daily Administration of Pioglitazone on Brain Hemodynamics in Healthy Elderly Participants (NCT01456117) | Takeda | 2011-11-01 |
| Safety, Pharmacodynamics (PD), Pharmacokinetics (PK) Study of SHP141 in 1A, 1B, or 2A Cutaneous T-Cell Lymphoma (CTCL) (NCT01433731) | TetraLogic Pharmaceuticals | 2011-11-01 |
| Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride (NCT02572609) | Boehringer Ingelheim | 2011-11-01 |
| Computer Vision System for the Blind Veteran (NCT00920231) | VA Office of Research and Development | 2011-11-01 |
| A Drug-Drug Interaction Study of Digoxin and PA21 (NCT01477411) | Vifor Pharma | 2011-11-01 |
| Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer (NCT01488552) | Pancreatic Cancer Research Team | 2011-11-01 |
| Treatment Study for Rural Latino Youth With Anxiety (NCT01491880) | University of California, San Diego | 2011-11-01 |
| A First-In-Human Study of RO5503781 in Participants With Advanced Malignancies Except Leukemia (NCT01462175) | Hoffmann-La Roche | 2011-11-01 |
| Safety and Efficacy of Cryoablation for the Palliation of Painful Bone Metastases (NCT01461265) | Boston Scientific Corporation | 2011-11-01 |
| A Study To Examine The Safety, Tolerability And Pharmacokinetics Of PF-04958242 In Psychiatrically Stable Subjects With Schizophrenia (NCT01518894) | Biogen | 2011-11-01 |
| A Study in Healthy Participants Investigating the Safety, Tolerability and Plasma Pharmacokinetics (PK) of Single Oral Doses of JNJ-47910382 (NCT01482611) | Janssen R&D Ireland | 2011-11-01 |
| Intranasal Modified Vacc-4x Gag Peptides With Endocine as Adjuvant (NCT01473810) | Oslo University Hospital | 2011-11-01 |
| Influence of Exercise on Anemia in MDS Patients (NCT01783249) | University of Rochester | 2011-11-01 |
| HIV Prevention in Very High Risk Men Who Have Sex With Men (NCT01291589) | Fenway Community Health | 2011-11-01 |
| Donepezil Trial for Motor Recovery in Acute Stroke (NCT01442766) | Imperial College London | 2011-11-01 |
| Single Rising Dose Study of BI 144807 Powder in Bottle in Healthy Male Volunteers (NCT01480648) | Boehringer Ingelheim | 2011-11-01 |
| In Vivo Dosimetry During Prostate Cancer Radiotherapy (NCT01307852) | M.D. Anderson Cancer Center | 2011-11-01 |
| Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL (NCT01523977) | Dana-Farber Cancer Institute | 2011-11-01 |
| An Exploratory Psoriasis Plaque Test Study With LEO 29102 Plus Calcipotriol, Ointment, in Psoriasis Vulgaris (NCT01466478) | LEO Pharma | 2011-11-01 |
| Phase I Trial of Tanibirumab in Advanced or Metastatic Cancer (NCT01660360) | PharmAbcine | 2011-11-01 |
| Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma (NCT01473095) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2011-11-01 |
| Repeated Dosing Study to Assess Safety and Tolerability in CKD-3 Patients on Stable ACE-I Treatment (NCT01485900) | Sanofi | 2011-11-01 |
| Omalizumab With Oral Food Immunotherapy With Food Allergies Open Label Safety Study in a Single Center (NCT01510626) | Stanford University | 2011-11-01 |
| A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor Cancers (NCT01436565) | Sanofi | 2011-11-01 |
| Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 557 in Adults With Psoriasis (NCT01493518) | Amgen | 2011-11-01 |
| Safety Study of OPC-12759 Ophthalmic Solution (NCT01471093) | Otsuka Pharmaceutical Co., Ltd. | 2011-11-01 |
| Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer (NCT01446458) | Emory University | 2011-11-01 |
| Panobinostat and Ruxolitinib in Primary Myelofibrosis, Post-polycythemia Vera-myelofibrosis or Post-essential Thrombocythemia-myelofibrosis (NCT01433445) | Novartis Pharmaceuticals | 2011-11-01 |
| A Study in Healthy Female Participants Investigating the Effect of TMC435 on the Pharmacokinetics of the Synthetic Hormones of the Oral Contraceptive Ovysmen (NCT01486004) | Tibotec Pharmaceuticals, Ireland | 2011-11-01 |
| Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis (NCT01464931) | Amgen | 2011-11-01 |
| A Study of RG1662 in Individuals With Down Syndrome (NCT01436955) | Hoffmann-La Roche | 2011-11-01 |
| Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide (NCT01432600) | H. Lee Moffitt Cancer Center and Research Institute | 2011-11-01 |
| Single Dose Study To Study The Absorption, Metabolism And Excretion Of PF-04991532 (NCT01469481) | Pfizer | 2011-11-01 |
| Compassionate Use of an Intravenous Fish Oil Emulsion in Infants With Cholestasis (NCT01601652) | Arthur J De Lorimier | 2011-11-01 |
| Study of Oral IXAZOMIB in Combination With Lenalidomide and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma (NCT01383928) | Millennium Pharmaceuticals, Inc. | 2011-10-31 |
| Double-blind, Multiple Dose Study of Tezepelumab (AMG 157) in Adults With Mild Atopic Asthma (NCT01405963) | Amgen | 2011-10-31 |
| A Single-Dose, Open-Label, Randomized, Food Effect and Blinded, Randomized, Dose Proportionality Study in Healthy Volunteers With Bardoxolone Methyl (NCT01461161) | Biogen | 2011-10-31 |
| Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia (NCT01555268) | Roswell Park Cancer Institute | 2011-10-31 |
| A Phase I Study of Epitinib(HMPL-813) in Patients With Advanced Solid Tumors (NCT02590952) | Hutchison Medipharma Limited | 2011-10-31 |
| Antiretroviral Drug Interaction Study in Volunteers With HIV (NCT01479361) | National Institutes of Health Clinical Center (CC) | 2011-10-31 |
| Long-term Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy for Treatment of Lower Extremity Bowen's Disease (NCT03320447) | Dong-A University | 2011-10-30 |
| Octanoic Acid for Essential Tremor (NCT01468948) | National Institute of Neurological Disorders and Stroke (NINDS) | 2011-10-28 |
| A Dose-escalation Study of Lipotecan® Plus Radiotherapy in Locally Advanced Hepatocellular Carcinoma (NCT01425996) | Taiwan Liposome Company | 2011-10-27 |
| A Phase 1 Study to Investigate the Mechanism of Action of Ipragliflozin (NCT01611363) | Astellas Pharma Europe B.V. | 2011-10-27 |
| An Adaptive Phase I Study to Evaluate the Safety, Efficacy and Dose Responses of Ronacaleret in Healthy Human Volunteers (NCT01466335) | GlaxoSmithKline | 2011-10-27 |
| A Study of the Safety and Activity of the MEK Inhibitor Given Together With the AKT Inhibitor to Patients With Multiple Myeloma or Solid Tumor Cancers (NCT01476137) | GlaxoSmithKline | 2011-10-26 |
| Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by Surgery (NCT01468896) | National Cancer Institute (NCI) | 2011-10-26 |
| Study of Changes in Hepatic Fat Following Administration of MK-4074 and Pioglitazone Hydrochloride (MK-4074-008) (NCT01431521) | Merck Sharp & Dohme LLC | 2011-10-26 |
| A Study of the Effect of MK-8457 on Blood Pressure in Hypertensive Participants (MK-8457-004-AM1) (NCT01446003) | Merck Sharp & Dohme LLC | 2011-10-25 |
| A Multiple Ascending Dose Study of ETC-1002 in Healthy Subjects (NCT01485146) | Esperion Therapeutics, Inc. | 2011-10-25 |
| A Study of LY3031207 in Healthy Subjects (NCT01449630) | Eli Lilly and Company | 2011-10-24 |
| TMC207 +/- Rifabutin/Rifampin (NCT01341184) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-10-21 |
| Assess the Safety and Pharmacokinetics of Ascending, Multiple Oral Doses of SPD489 in Adults With Schizophrenia (NCT01457339) | Shire | 2011-10-21 |
| A Study of Doravirine (MK-1439) in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439-005) (NCT01466985) | Merck Sharp & Dohme LLC | 2011-10-21 |
| A Four Part Study to Investigate Relative Bioavailability, Safety and Tolerability of up to 5 Oral Formulation of GSK2251052 in Order to Identify a Formulation for Further Evaluation in a Future Later Phase Study (NCT01702350) | GlaxoSmithKline | 2011-10-21 |
| Intranasal Challenge of Healthy Adults With Respiratory Syncytial Virus (RSV) (NCT01475305) | MedImmune LLC | 2011-10-20 |
| Fluorescence Imaging in Finding Tumors in Patients With Kidney Tumors (NCT01281488) | City of Hope Medical Center | 2011-10-20 |
| Study to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung Cancer (NCT01471964) | Fox Chase Cancer Center | 2011-10-20 |
| The Safety, Tolerability, PK and PD of GSK2339345 in Healthy Subjects (NCT01494636) | GlaxoSmithKline | 2011-10-17 |
| Immune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignancy: A Single-arm Phase I Trial in Melanoma (NCT01456104) | Memorial Sloan Kettering Cancer Center | 2011-10-17 |
| Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies (NCT01416428) | Amgen | 2011-10-15 |
| A Bioequivalence Study Comparing Methylprednisolone Suspension to Methylprednisolone Tablets Under Fed Conditions (NCT01405170) | Pfizer | 2011-10-14 |
| The Effects of Ginseng on Cancer-Related Fatigue (NCT01375114) | M.D. Anderson Cancer Center | 2011-10-14 |
| SAP Depleter Dose Assessment Study in Patients (NCT01406314) | GlaxoSmithKline | 2011-10-13 |
| A Study of E7050 in Combination With E7080 in Participants With Advanced Solid Tumors (Dose Escalation) and in Participants With Recurrent Glioblastoma or Unresectable Stage III or Stage IV Melanoma After Prior Systemic Therapy (Expansion Cohort and Phase 2) (NCT01433991) | Eisai Inc. | 2011-10-13 |
| Liver Cell Transplant for Phenylketonuria (NCT01465100) | Ira Fox | 2011-10-12 |
| A Study to Look at How GSK1325756 is Taken up by the Body When Given by Mouth When Stomach Acid is Reduced (NCT01453478) | GlaxoSmithKline | 2011-10-12 |
| Assessment of Lung Function After Single Inhalations of a Bronchodilator From 2 Configurations a Dry Powder Inhaler. (NCT01521390) | GlaxoSmithKline | 2011-10-12 |
| Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer (NCT01459380) | National Cancer Institute (NCI) | 2011-10-11 |
| Gabapentin and Donepezil Combination on Experimental Human Pain Models (NCT01485185) | GlaxoSmithKline | 2011-10-11 |
| Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma (NCT01468311) | National Cancer Institute (NCI) | 2011-10-11 |
| Study to Evaluate the Pharmacokinetics of Mucinex® 1200 mg Extended-Release Tablet (NCT03633487) | Reckitt Benckiser LLC | 2011-10-11 |
| Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients (NCT01430572) | M.D. Anderson Cancer Center | 2011-10-07 |
| Amoxicillin Drug Interaction Study With MMX® Mesalazine/Mesalamine (NCT01442688) | Shire | 2011-10-07 |
| Modified White Blood Cells That Secrete IL-2 and Express a Protein That Targets the ESO-1tumor Protein for Metastatic Cancer (NCT01457131) | National Cancer Institute (NCI) | 2011-10-06 |
| Study of ABT-700 in Subjects With Advanced Solid Tumors (NCT01472016) | AbbVie (prior sponsor, Abbott) | 2011-10-06 |
| AZD7451 for Recurrent Gliomas (NCT01468324) | National Cancer Institute (NCI) | 2011-10-05 |
| A 2-Part Single Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006 (NCT01463098) | Eisai Inc. | 2011-10-05 |
| Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia (NCT01380756) | Amgen | 2011-10-04 |
| Administration of T Lymphocytes for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma (CART CD30) (NCT01316146) | UNC Lineberger Comprehensive Cancer Center | 2011-10-03 |
| A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR (NCT01570296) | National Cancer Centre, Singapore | 2011-10-03 |
| Pharmacokinetics and Bioequivalence of Vycavert (10 mg Hydrocodone Bitartrate/325 mg Acetaminophen) Compared to the Reference Drug Norco (NCT01456520) | Pfizer | 2011-10-01 |
| Pharmacokinetic and Safety Study of SPARC1023 Alone and in Carboplatin Combination (NCT01304303) | Sun Pharma Advanced Research Company Limited | 2011-10-01 |
| A Study on the Effect of Renal Impairment on the Pharmacokinetics of RO4917838 (NCT01510899) | Hoffmann-La Roche | 2011-10-01 |
| Feasibility of Mid-frequency Ventilation in Newborns With RDS: Randomized Crossover Pilot Trial (NCT01242462) | University of Alabama at Birmingham | 2011-10-01 |
| Safety and Efficacy of an Injectable Medical Device to Treat Knee Osteoarthritis (NCT01365260) | Moebius Medical Ltd. | 2011-10-01 |
| Mindfulness-Oriented Recovery Enhancement for Chronic Pain Patients Receiving Opioid Therapy (NCT01505101) | Florida State University | 2011-10-01 |
| Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects (NCT01450046) | H. Lee Moffitt Cancer Center and Research Institute | 2011-10-01 |
| An Evaluation of the Biodistribution and Imaging Characteristics of ABT-806i (111In-ABT-806) in Subjects With Advanced Solid Tumor Types (NCT01472003) | AbbVie (prior sponsor, Abbott) | 2011-10-01 |
| Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0941 Following Single Oral Dose Administration in Healthy Male Subjects (NCT01474668) | Genentech, Inc. | 2011-10-01 |
| A Study in Healthy Participants Investigating the Effect of TMC435 on the Pharmacokinetics of Immunosuppressants Cyclosporine and Tacrolimus (NCT01479881) | Tibotec Pharmaceuticals, Ireland | 2011-10-01 |
| A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers (NCT01451632) | Merrimack Pharmaceuticals | 2011-10-01 |
| Pharmacokinetic and Biomarker Study of Pioglitazone in Adolescents With Severe Sepsis and Septic Shock (NCT01352182) | Children's Hospital Medical Center, Cincinnati | 2011-10-01 |